Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Concurrent Schistosoma mansoni infection suppresses induction of HIV-1 Env-specific antibodies in a DNA-MVA-gp140 Env vaccine regimen in rhesus macaques
Gerald K. Chege; Rosamund E. Chapman; Asisipho Mzukwa; Alana T. Keyser; Craig H. Adams; Michiel T. van Diepen; Nicola Douglass; Nonkululeko Mzindle; Qiniso Mkhize; Penny L. Moore; Anna-Lise WilliamsonShow moreShow less
1. South African Medical Research Council; 2. University of Cape Town; 3. University of the Witwatersrand; 4. A Division of the National Health Laboratory Service; 5. University of KwaZulu-NatalShow moreShow less
Vaccination coverage, dropout and predictors of schedule-complete vaccination among children aged 0–59 months in Gushegu and Nanumba South districts, northern Ghana: A cross-sectional study
Matthew Konlan; Rajan Bhandari; Hilarius Asiwome Kosi Abiwu; Sheila Agyeiwaa Owusu; Amos Nunifant; Sheryl Weyere Adongo; Michael Rockson Adjei; Fuseini Mahama; Chrysantus Kubio; Timothy RobertonShow moreShow less
1. University of Western Australia; 2. Ghana Health Service; 3. University for Development Studies; 4. London School of Hygiene and Tropical Medicine; 5. International Organisation for Migration; 6. Savelugu Municipal Hospital; 7. WHO Country Office for GhanaShow moreShow less
A qualitative evaluation of a STEAM (Science, technology, engineering, arts, and mathematics) peer education intervention on teenagers’ knowledge, confidence, and advocacy for HPV vaccine communication
Carol Gray Brunton; Iain Macdonald; Céline Healy; Richard Firth; Alexandra McDermott; Eva MaloneShow moreShow less
1. Edinburgh Napier University; 2. Maynooth University; 3. Glanbia Business ServicesShow moreShow less
From metastatic disease to no evidence of disease after conversion liver surgery in advanced gastric cancer with liver metastases: A case report
Dong Chen; Hanyu Wang; Lin XuShow moreShow less
1. Chinese Academy of Medical Sciences and Peking Union Medical CollegeShow moreShow less
Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China
Xuanwen Shi; Shasha Han; Cong Wu; Xuejuan Wang; Jiao Huang; Wei Chen; Xiaoqin Liu; Sheng Wei; Jun Liu; Xiang Guo; Chenhao Wang; Shengyi Wang; Min Zhang; Xue Guo; Wei Zhao; Haiping Chen; Qingliang LiShow moreShow less
1. China National Biotec Group Company Limited; 2. Wuhan Institute of Biological Products Co., Ltd; 3. National Engineering Technology Research Center for Combined Vaccines; 4. Zhongnan Hospital of Wuhan University; 5. National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases; 6. Huazhong University of Science and Technology; 7. Changchun Institute of Biological Products Co., Ltd; 8. Chengdu Institute of Biological Products Co., LtdShow moreShow less
Implementing single-dose HPV vaccination in Canada
Madison Leggatt; Nivatha Moothathamby; Ève Dubé; Gilla K. ShapiroShow moreShow less
1. University Health Network (UHN); 2. Laval University; 3. University of TorontoShow moreShow less
FAQ
How long does Human Vaccines & Immunotherapeutics take to review a manuscript?
As of 2026-11-19, CrushSCI has 21 complete review records for Human Vaccines & Immunotherapeutics. The fastest paper went from submission to acceptance in 62 days (Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China, received 2026-08-06, accepted 2026-10-07); the slowest took 189 days. The average is 116.0 days and the median is 114 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
